Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Telethon smashes records as West Australians dig deep for sick kids

Huge congratulations to Telethon on another record-breaking year, with generous West Australians donating just over $38 million to help sick kids.

ORIGINS reaches key milestone

ORIGINS, a collaboration between The Kids and the Joondalup Health Campus, has achieved a major milestone – recruiting its 1000th family.

Stan Perron Charitable Foundation grants boost WA child health research

New funding from the Stan Perron Charitable Foundation will support innovative research projects and programs at The Kids Research Institute Australia with the aim of improving the health and wellbeing of WA children and their families. 

Newborn Nasal Sampling Evaluation (NOSE) Study

A pilot study to assess recruitment and nasal sampling in newborns.

ORIGINS sub-project awarded substantial Channel 7 Telethon Trust grant to support disadvantaged children

STARS for Kids, a sub-project of ORIGINS, received a three-year grant to advance the development of a scalable, online, tiered model of care to better support disadvantaged communities, where 20-25 per cent of children are entering school developmentally vulnerable.

Indigenous researcher awarded prestigious Forrest Fellowship

Outstanding Aboriginal researcher Jessica Buck has received a prestigious Forrest Foundation Research Fellowship to investigate innovative new therapies for children with brain cancer.

Associate Professor Nick Gottardo awarded Cure Brain Cancer Foundation Innovation Grant 2017

The Kids cancer researcher & clinician Dr Nick Gottardo has been announced as the recipient of an Innovation Grant from the Cure Brain Cancer Foundation.

Statistical modeling based on structured surveys of Australian native possum excreta harboring Mycobacterium ulcerans predicts Buruli ulcer occurrence in humans

Buruli ulcer (BU) is a neglected tropical disease caused by infection of subcutaneous tissue with Mycobacterium ulcerans. BU is commonly reported across rural regions of Central and West Africa but has been increasing dramatically in temperate southeast Australia around the major metropolitan city of Melbourne, with most disease transmission occurring in the summer months.

Neonatal high-frequency oscillatory ventilation: where are we now?

High-frequency oscillatory ventilation (HFOV) is an established mode of respiratory support in the neonatal intensive care unit. Large clinical trial data is based on first intention use in preterm infants with acute respiratory distress syndrome. Clinical practice has evolved from this narrow population. HFOV is most often reserved for term and preterm infants with severe, and often complex, respiratory failure not responding to conventional modalities of respiratory support.

Neonatal high frequency ventilation: Current trends and future directions

High frequency ventilation (HFV) in neonates has been in use for over forty years. Some early HFV ventilators are no longer available, but high frequency oscillatory ventilation (HFOV) and jet ventilators (HFJV) continue to be commonly employed. Advanced HFOV models available outside of the United States are much quieter and easier to use, and are available as options on many conventional ventilators, providing important improvements such as tidal volume measurement and targeting.